Carbohydrate plasma expanders for passive tumor targeting: In vitro and in vivo studies

Carbohydrate Polymers

Volumn 95, Issue 1, 2013, Pages 404-413

  Hoffmann, Stefan ^a   Caysa, Henrike ^a   Kuntsche, Judith ^b   Kreideweiß, Patrick ^a   Leimert, Anja ^a   Mueller, Thomas ^a   Mäder, Karsten ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cytokine induction; HES; Hydroxyethyl starch; Multispectral optical imaging; Passive tumor targeting; Tumor accumulation

Indexed keywords

CYTOKINES; HES; HYDROXYETHYL STARCHES; MULTI-SPECTRAL OPTICAL IMAGING; TUMOR ACCUMULATION; TUMOR TARGETING;

BIODEGRADABLE POLYMERS; BIODEGRADATION; CARBOHYDRATES; CELL CULTURE; CONJUGATED POLYMERS; MAMMALS; MOLECULAR WEIGHT DISTRIBUTION; OPTICAL IMAGE STORAGE; PLASMAS; STARCH;

TUMORS;

CYTOKINE; DEXTRAN; HETASTARCH; PLASMA SUBSTITUTE;

ANIMAL; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CELL SURVIVAL; CHEMISTRY; COLON TUMOR; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; MALE; METABOLISM; MONONUCLEAR CELL; MOUSE; NUDE MOUSE; PATHOLOGY; TISSUE DISTRIBUTION; TUMOR VOLUME;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; COLONIC NEOPLASMS; CYTOKINES; DEXTRANS; FEMALE; HEP G2 CELLS; HETASTARCH; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, NUDE; PLASMA SUBSTITUTES; TISSUE DISTRIBUTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 84875388402     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.03.033     Document Type: Article

References (53)

1. M.L. Adams, A. Lavasanifar, and G.S. Kwon Amphiphilic block copolymers for drug delivery Journal of Pharmaceutical Sciences 92 2003 1343 1355 (Pubitemid 36792748)
2. Y. Bae, and K. Kataoka Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers Advanced Drug Delivery Reviews 61 2009 768 784
3. M. Baggiolini, and I. Clark-Lewis Interleukin-8, a chemotactic and inflammatory cytokine FEBS Letters 307 1992 97 101
4. A. Besheer, T.C. Hertel, J. Kressler, K. Mäder, and M. Pietzsch Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility Journal of Pharmaceutical Sciences 98 2009 4420 4428
5. H.W. Bowman Clinical evaluation of dextran as a plasma volume expander Journal of the American Medical Association 153 1953 24 26
6. M. Brinkley A brief survey of methods for preparing protein conjugates with dyes, haptens and crosslinking reagents Bioconjugate Chemistry 3 1992 2 13
7. H. Caysa, H. Metz, K. Mäder, and T. Mueller Application of Benchtop-magnetic resonance imaging in a nude mouse tumor model Journal of Experimental & Clinical Cancer Research 2011 30
8. R.E. Collis, P.W. Collins, C.N. Gutteridge, A. Kaul, A.C. Newland, and D.M. Williams The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study Intensive Care Medicine 20 1994 37 41 (Pubitemid 24056295)
9. W.H. De Jong, W.I. Hagens, P. Krystek, M.C. Burger, A.J.A.M. Sips, and R.E. Geertsma Particle size-dependent organ distribution of gold nanoparticles after intravenous administration Biomaterials 29 2008 1912 1919
10. R. Duncan Development of HPMA copolymer-anticancer conjugates: Clinical experience and lessons learnt Advanced Drug Delivery Reviews 61 2009 1131 1148
11. R. Duncan, H. Ringsdorf, and R. Satchi-Fainaro Polymer therapeutics: Polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities Advances in Polymer Science 192 2006 1 8
12. D.M. Euhus, C. Hudd, M.C. Laregina, and F.E. Johnson Tumor measurement in the nude mouse Journal of Surgical Oncology 31 1986 229 234 (Pubitemid 16104025)
13. H.P. Ferber, E. Nitsch, and H. Förster Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers Arzneimittel-Forschung 35 1985 615
14. E. Folta-Stogniew, and K. Williams Determination of molecular masses of proteins in solution: implementation of an HPLC size exclusion chromatography and laser light scattering service in a core laboratory Journal of Biomolecular Techniques 10 1999 51 63
15. M.C. Garnett Targeted drug conjugates: Principles and progress Advanced Drug Delivery Reviews 53 2001 171 216 (Pubitemid 33135563)
16. U. Gaur, S.K. Sahoo, T.K. De, P.C. Ghosh, A. Maitra, and P.K. Ghosh Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system International Journal of Pharmaceutics 202 2000 1 10 (Pubitemid 30466224)
17. E.R. Gillies, and J.M.J. Frechet Dendrimers and dendritic polymers in drug delivery Drug Discovery Today 10 2005 35 43 (Pubitemid 40164817)
18. N. Goodarzi, R. Varshochian, G. Kamalinia, F. Atyabi, and R. Dinarvand A review of polysaccharide cytotoxic drug conjugates for cancer therapy Carbohydrate Polymers 92 2012 1280 1293
19. R. Haag, and F. Kratz Polymer therapeutics: Concepts and applications Angewandte Chemie International Edition 45 2006 1198 1215 (Pubitemid 44097641)
20. T. Hey, H. Knoller, and P. Vorstheim Half-life extension through HESylation Therapeutic proteins: Strategies to modulate their plasma half-lives 2011 Wiley Online Library 117 140
21. S. Hoffmann, L. Vystrcilová, K. Ulbrich, T. Etrych, H. Caysa, and T. Mueller Dual fluorescent HPMA copolymers for passive tumour targeting with pH-sensitive drug release: Synthesis and characterisation of distribution and tumour accumulation in mice by noninvasive multispectral optical imaging Biomacromolecules 13 2012 652 653
22. A.E. Koch, P.J. Polverini, S.L. Kunkel, L.A. Harlow, L.A. DiPietro, and V.M. Elner Interleukin-8 as a macrophage-derived mediator of angiogenesis Science (New York, NY) 258 1992 1798
23. J. Kopecek, and P. Kopeckova HPMA copolymers: Origins, early developments, present, and future Advanced Drug Delivery Reviews 62 2010 122 149
24. W.M. Kulicke, U. Kaiser, D. Schwengers, and R. Lemmes Measurements of the refractive index increment on hydroxyethyl starch as a basis for absolute molecular weight determinations Starch 43 1991 392 396
25. W.M. Kulicke, D. Roessner, and W. Kull Characterization of hydroxyethyl starch by polymer analysis for use as a plasma volume expander Starch 45 1993 445 450
26. T. Lammers, and K. Ulbrich HPMA copolymers: 30 years of advances Advanced Drug Delivery Reviews 62 2010 119 121
27. F. Leblond, S.C. Davis, P.A. Valdes, and B.W. Pogue Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications Journal of Photochemistry and Photobiology B: Biology 98 2010 77 94
28. W.H. Lee Jr.; N. Cooper, M.G. Weidner Jr.; and E.S. Murner Clinical evaluation of a new plasma expander, hydroxyethyl starch The Journal of Trauma 8 1968 381
29. R. Lv, W. Zhou, L.D. Zhang, and J.G. Xu Effects of hydroxyethyl starch on hepatic production of cytokines and activation of transcription factors in lipopolysaccharide-administered rats Acta Anaesthesiologica Scandinavica 49 2005 635 642 (Pubitemid 40593507)
30. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Advances in Enzyme Regulation 41 2001 189 207
31. H. Maeda, and Y. Matsumura EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy Advanced Drug Delivery Reviews 63 2011 129 130
32. R. Matsubayashi, Y. Matsuo, G. Edakuni, T. Satoh, O. Tokunaga, and S. Kudo Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: Correlation of MR findings with histologic features and expression of growth factors1 Radiology 217 2000 841 848
33. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Research 46 1986 6387 6392 (Pubitemid 17221789)
34. S. Mizrahy, and D. Peer Polysaccharides as building blocks for nanotherapeutics Chemical Society Reviews 41 2012 2623 2640
35. J. Morita, H. Nakatsuji, T. Misaki, and Y. Tanabe Water-solvent method for tosylation and mesylation of primary alcohols promoted by KOH and catalytic amines Green Chemistry 7 2005 711 715 (Pubitemid 41457406)
36. R.J. Navickis, G.R. Haynes, and M.M. Wilkes Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-analysis of randomized trials Journal of Thoracic and Cardiovascular Surgery 144 2012 223-230.e5
37. M. Nishikawa, A. Kamijo, T. Fujita, Y. Takakura, H. Sezaki, and M. Hashida Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting Pharmaceutical Research 10 1993 1253 1261 (Pubitemid 23261822)
38. M. Noga, D. Edinger, W. Rödl, E. Wagner, G. Winter, and A. Besheer Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase Journal of Controlled Release 159 2012 92 103
39. D.E. Owens, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles International Journal of Pharmaceutics 307 2006 93 102 (Pubitemid 41773257)
40. A. Perner, N. Haase, A.B. Guttormsen, J. Tenhunen, G. Klemenzson, and A. Åneman Hydroxyethyl starch 130/0.4 versus Ringer's acetate in severe sepsis New England Journal of Medicine 367 2012 124 134
41. A. Schädlich, S. Hoffmann, T. Mueller, H. Caysa, C. Rose, and A. Göpferich Accumulation of nanocarriers in the ovary: A neglected toxicity risk? Journal of Controlled Release 160 2012 105 112
42. A. Schädlich, C. Rose, J. Kuntsche, H. Caysa, T. Mueller, and A. Göpferich How stealthy are PEG-PLA nanoparticles? An NIR in vivo study combined with detailed size measurements Pharmaceutical Research 28 2011 1995 2007
43. G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Advanced Drug Delivery Reviews 17 1995 31 48
44. J. Tian, X. Lin, Y.H. Li, and J.G. Xu Influence of hydroxyethyl starch on lipopolysaccharide-induced tissue nuclear factor kappa B activation and systemic TNF-γ expression Acta Anaesthesiologica Scandinavica 49 2005 1311 1317 (Pubitemid 41375056)
45. M.M. Tomayko, and C.P. Reynolds Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemotherapy and Pharmacology 24 1989 148 154 (Pubitemid 19163397)
46. J. Treib, A. Haass, G. Pindur, U.T. Seyfert, W. Treib, and M.T. Grauer HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics Thrombosis and Haemostasis 74 1995 1452 1456 (Pubitemid 26018072)
47. K. Ulbrich, V. Subr, J. Strohalm, D. Plocova, M. Jelinkova, and B. Rihova Polymeric drugs based on conjugates of synthetic and natural macromolecules: I. Synthesis and physico-chemical characterisation Journal of Controlled Release 64 2000 63 79 (Pubitemid 30035308)
48. M.J. Vicent, H. Ringsdorf, and R. Duncan Polymer therapeutics: Clinical applications and challenges for development Advanced Drug Delivery Reviews 61 2009 1117 1120
49. J.L. Vincent The pros and cons of hydroxyethyl starch solutions Anesthesia & Analgesia 104 2007 484 486
50. R. Weissleder A clearer vision for in vivo imaging Nature Biotechnology 19 2001 316 317
51. S. Wöhl-Bruhn, M. Badar, A. Bertz, B. Tiersch, J. Koetz, and H. Menzel Comparison of in vitro and in vivo protein release from hydrogel systems Journal of Controlled Release 162 2012 127 133
52. S. Wöhl-Bruhn, A. Bertz, S. Harling, H. Menzel, and H. Bunjes Hydroxyethylstarch-based polymers for the controlled release of biomacromolecules from hydrogel microspheres European Journal of Pharmaceutics and Biopharmaceutics 81 2012 573 581
53. M. Yoshida, M. Amino, and T. Kishikawa A study of hydroxyethyl starch. Long pursuit of hydroxyethyl starch after consecutive infusions into rabbits Starch 36 1984 240 246